Tag: pharma procurement intelligence

ir10

Increasing Health Awareness Amongst Consumers Driving Demand in the Global Cardamom Oil Market

Cardamom Oil Market - Procurement Market Intelligence Report InfographicsLondon, Apr 04, 2018: Increased demand from end-use industries such as food and beverage and cosmetics is driving the global market growth as cardamom oil is widely used as a raw material in these industries. Additionally, is also used in ayurvedic rehabilitation centers for aromatherapy due to its antimicrobial and antioxidant properties.

SpendEdge’s latest procurement research report on the global cardamom oil market offers an in-depth assessment of the crucial factors influencing the supply market, strategic procurement and sourcing decisions, pricing models, and procurement best practices. The report, a part of the agro commodities and raw materials, also offers detailed insights into the supply chain management, key market developments, and demand-supply shifts to help sourcing and procurement experts make smart procurement decisions.

“Consumers in the food and beverage industry prefer healthy diet to overcome diseases such as diabetes, cardiovascular related diseases, digestive problems, and respiratory disorders. Consumers are demanding cardamom oil as it is a healthy substitute for regular oil” – Tridib Bora, Agro commodities and raw materials expert at SpendEdge.

There is lack of transparency in the supply chain of cardamom oil suppliers. Cardamom seeds/pods used to produce cardamom oil are brought from small farmers that are opaque about their farming practices, leading to decreased visibility in terms of cardamoms’ quality used in the production process. As a result, buyers are facing procurement challenges regarding the supply chain traceability of the cardamom oil.

Need more insights on this report?

Request Free SampleThis procurement report on the cardamom oil market offers insights on:

  • Supply markets, growth drivers, trends, and imminent restraints
  • Key suppliers and assessment of their capabilities
  • Procurement best practices
  • Negotiation strategies and cost-saving opportunities
  • Pricing models and category innovations
  • For a comprehensive, detailed list, view our full report

Get unlimited access to all our reports. Get access to our reports to gain insights, platform ready-to-use procurement research reports, latest supplier news, innovation landscape, markets insights, supplier tracking, and much more at the click of a button. Request a free demo now


Related posts 

photo

Top Trends in the Pharmaceutical Analytical Testing Services Market

The rising cost of drug development process has urged pharmaceutical companies to look out for ways to reduce the overall cost and time. The pharma industry turns towards highly specialized contract research organizations (CROs) who depict expertise in drug discovery assistance, regulatory compliance, lead identification, clinical data management, consultation, clinical trials, and project management. Pharmaceutical analytical testing is one of the research support services rendered by CROs and contract laboratories to pharmaceutical manufacturers. These organizations use various processes to analyze the intermediate drug ingredients and final drugs, so that the quality of the medication can be ensured. Toxicological risk assessments, environmental monitoring, clinical and non-clinical bioanalysis, stability testing, method validation, preclinical research, and biological assay development are some of the services under pharmaceutical analytical testing. The procurement market intelligence report predicts a healthy growth rate of 7.71% for the pharmaceutical testing market.

Request Free SampleTrends in the Pharmaceutical Testing Market

Capability Enhancement Toward Analytical Testing of Biosimilars

Numerous drugs in the pharma industry are nearing the end of their patent lifetime. This has led pharmaceutical companies to divert their attention to biosimilars from biologics. Such move has motivated pharmaceutical testing companies to enhance their capabilities in the analytical testing of biosimilars. Compatibility studies for biosimilars, stability testing, product release testing, and protein analysis of biosimilars are some of the capabilities suppliers have been focusing. Consequently, enhancement of such capabilities reduces the risks associated with drug development.

Rising Demand from Nutraceuticals Industry

Traditionally, the pharmaceutical testing services were availed mainly by the pharmaceutical companies. However, today that trend looks to be slowly changing as nutraceuticals industry is also emerging as an active consumer of these services. This surge in demand can be attributed to increasing regulations for nutraceutical manufacturing companies demanding them to get their raw materials tested for quality and conduct release testing for their products.

Adoption of FTE-based Contracts

Since a long time, pharmaceutical testing service providers have been charging their clients on a per contract or per sample basis. Such pricing strategy is slowly changing as suppliers are looking to charge their clients on FTE-based contracts irrespective of workload, compound, or analytical technique used. The supplier allocates a dedicated team during the tenure of the project and manages the project resources along with the client. Such contracts ensure that the dedicated team members acquire a strong knowledge of the procedures and requirements of the project leading to fewer errors and higher consistency in the output.

Technological Advancements in Analytical Testing Equipment

The pharma industry is pressurizing pharmaceutical testing companies to reduce the testing time for drug ingredients forcing the suppliers to use advanced equipments and processes. For the same reason, the majority of the suppliers are now using HRAM instruments that allow users to identify the target molecule confidently. Additionally, several suppliers are now actively using morphologically-directed Raman spectroscopy, which is based on a combination of Ramana spectroscopy and automated imaging. Use of advanced equipment eliminates the need to perform multiple trials and subsequently increases the reliability and accuracy of pharmaceutical testing.

Read more about the trends in the pharmaceutical testing market along with sourcing strategies, pricing insights, top pharmaceutical analytical testing service providers, procurement challenges, and pricing models in SpendEdge’s upcoming report on the global pharmaceutical analytical testing services market.

CTA view full reportRelated Articles:

IR3

Top 5 CRO Companies to Depend on for Drug Development

Typically, the cost of developing a drug costs pharmaceutical companies millions of dollars and sometimes even touching the billion dollar market. The development process goes through multiple stages which can last about 10-12 years. In the changing economy, pharmaceutical companies have to look for ways to control such costs and ensure compliance against stringent regulations. As a result, the pharma industry is looking to outsource the drug development process to Contract Research Organization (CRO) companies. CRO companies partner with various drug companies and thereby gather vast experiences in conducting clinical trials and testing out the efficacy of the new drug. CRO service providers offer services including drug discovery assistance, clinical data management, consultation, regulatory compliance, lead identification, clinical trials, and project management. The recent procurement market intelligence report on global pharmaceutical drug development services market estimates the market to grow at a rate of 7.35% during the forecast period.

Request Free SampleTop CRO Companies to Watch Out

IQVIA

IQVIA, formerly known as Quintiles IMS Holdings, is one of the leading CRO companies involved in the field of biopharmaceutical development and outsourcing services alongside depicting expertise in healthcare database and analytical services. The company is the world’s largest contract research organization and specializes in phase II-IV trials. The company was formed as a result of the merger between Quintiles Transnational and IMS Health in 2016. It is also the world’s largest CRO company based on market revenue with the company posting revenues of US$6.87 billion in 2016.

LabCorp

LabCorp is an American company and one of the leading CRO companies in the world. Currently, with close to 40 clinical laboratories in the US, it has one of the largest networks of clinical labs in the world. With more than 50,000 employees serving more than 220,000 clients across 60 countries, the company generated revenues of US$9.43 billion in 2016. The company is the pioneer in the field of using polymerase chain technology for genomic technology and also exhibits expertise in oncology trials, HIV genotyping, and phenotyping.

PAREXEL

PAREXEL is a world-renowned life sciences consulting firm that helps pharma companies develop approximately 95% of the 200 top-selling biopharmaceuticals on the market. Leading pharma companies such as Catalent Inc, Merck & Co. Inc., Pfizer Inc., ICON plc, and GlaxoSmithKline plc all depend on PARAXEL for new drug development. In June 2017, the company announced that it is set to be acquired by Pamplona Capital for US$5 billion.

ICON

ICON is a global provider of outsourced drug development services depicting expertise in the field of late phase services. In fact, it is the world’s second-largest player in the field of late phase services in terms of market share. Their services range from clinical, consulting, and commercial services, which incorporate trial design and full study execution. The company is renowned for its exceptional quality management system subjected to more than 1,700 successful audits by buyers, regulatory bodies, and ISO. They also offer knowledge, software, and systems for adaptive trials.

INC Research

INC Research is one of the leading CRO companies known for ‘The Trusted Process,’ a proprietary trial management methodology developed by the company. The company recently merged its operations with inVentive Health to expand the global scale and add capabilities. Their key services include early phase trials, phase II and III trials, late phase trials, consulting, and clinical monitoring.

Read more about the top CRO companies along with CRO services, clinical trials, drug development, pricing strategy, procurement challenges, and supplier evaluation criteria in SpendEdge’s upcoming report on the global pharmaceutical drug development services market.

CTA view full reportRelated Articles:

IR14

The Biggest Problems with Pharmaceutical Raw Materials Market, And How You Can Fix It

If you were to ever glance on the packaging of medicines, it would enlist the chemicals and composition used to manufacture that drug. However, chemicals are not the only raw material used in the pharmaceutical manufacturing process. Pharmaceutical raw materials also include natural raw materials like leaves, flowers, fruits, fungi, and seeds, in addition to synthetic materials and biologics. Pharmaceutical raw materials are classified into three groups namely active pharmaceutical ingredients (APIs), intermediaries, and additives. The pharmaceutical industry relies heavily on chemical suppliers and biologics manufacturers for their pharmaceutical supplies. The pharmaceutical industry has been witnessing stable growth with higher growth prospects in emerging regions such as the APAC, which is expected to grow at a CAGR of nearly 9%-10% by 2021. (SpendEdge Procurement Market Intelligence Report – Bulk Drug Raw Materials Market) Although the growth prospects look promising for the pharmaceutical industry, suppliers of pharmaceutical raw materials have been facing tough challenges that affect their growth.

Request Free Sample

Top Challenges in the Pharmaceutical Raw Materials Market

Threat from Counterfeit Products

Falsified medicines or counterfeit drug products can easily enter the pharma supply chain across the world. Counterfeit drugs, usually contain low-quality APIs, wrong ingredient, or even the incorrect dosages. Such counterfeit products are then fraudulently mislabeled without compliance with intellectual property rights and can cause side-effects and other complexities when consumed. Pharmaceutical raw materials manufacturers will be negatively affected by such acts. As a result, medicine surveillance services and fake -identification technologies such as mass spectrometry (MS), infra-red (FTIR) spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, Raman spectroscopy, and gas chromatography-mass spectrometry (GC-MS) are gaining prominence.

Increase in Trade Taxes

Manufacturing hubs of the final drug products are located in the primary markets such as the US and Europe. However, these companies procure pharmaceutical raw materials from emerging countries like Brazil, China, India, and Israel. The problem arises when drug manufacturers have to incur additional expenses in the form of trade taxes and customs expenses. To promote “Made in America” movement, the Trump administration has slapped a double-digit tariff for companies outsourcing drug manufacturing activities. Such regulations will discourage drug manufacturers to obtain pharmaceutical raw materials at a lower cost.

Increase in Regulatory Delays

Drugs and medicines being a sensitive matter regarding public health, are heavily regulated by governments and medical associations. Pharmaceutical raw materials suppliers, therefore, must obtain approval from regulatory bodies such as FDA and EMA to bring the final products to the market. Delays in the approval process can slow down the time-to-market, and risk expiry of patent validity along with other operational issues. Such delays severely affect the drug manufacturers profitability, thereby hindering the overall growth of the market.

Read more about the top challenges in the pharmaceutical raw materials market along with competitive landscape analysis, contract and SLA terms, pricing strategies, sourcing strategy, and procurement market intelligence in SpendEdge’s upcoming report on the global beef market.

CTA view full reportRelated Articles:

IR2

Top 4 Trends Driving the Productivity of Pharmaceutical Supply Chain

It is very characteristic of a pharma company to invest millions of dollars in new drug development with very little success rate. They then face pressure from governments and consumers to keep the prices of such medicines low for it to be accessible to everyone. Consequently, pharma companies are looking for new ways to increase their revenue stream and improve efficiency in every aspect of their business. Innovations in pharma procurement along with advancements in technology can significantly boost profitability in the pharma industry and provide them a competitive advantage.SE_Demo2

Current Trends in Pharmaceutical Industry

Reinvesting in R&D Process

For a very long time, big pharma players in this industry were relying on old techniques and technology for drug discovery. Since companies started using big data analytics, they have significantly improved their success rates for drug discovery. Additionally, using real-world evidence has equipped them to speed up the drug discovery process, decrease R&D costs, and improve time-to-market.

Resource Reallocation in the Emerging Markets

The pharma industry has been shifting its focus from developed nations to emerging markets as the growth curve in the developed parts of the world continues to flatten. The emerging markets which are relatively underserved have a vast growth potential for key suppliers in the pharma industry. The suppliers are exploring ways to increase the efficiency of the pharmaceutical supply chain by identifying potential locations for developing and manufacturing medicines. For instance, the developed parts of the world are looking at the Asian and Latin American region to outsource the process of clinical research.

New Modes of Healthcare Delivery

Hospitals and healthcare specialists are driving up the overall cost of healthcare. Companies are looking for ways to cut down costs and improve outcomes by trying to reduce reliance on hospitals and specialists. The recent advancements in medicines along with technological advancements such as fitness tracker and health monitoring devices has made self-medication and telemedicine possible. Such disruption in the pharmaceutical supply chain could significantly improve the costs, efficiency, and profitability of the pharma industry.

Increasing Emphasis on Outcomes

The increasing emphasis on outcomes is the most prominent pharma trend currently. Majority of the players in the pharma industry are modifying their existing models such as a fee for service models in favor of outcome-based models. Such measures help reduce wastages and fraud mostly in the healthcare reimbursement sector. The pharmaceutical supply chain needs to be highly active by closely supervising and monitoring the value delivery process to the patients in order to improve outcomes.

For more information on how optimization of pharmaceutical supply chain, pharma trends, pharma manufacturing, and pharmaceutical procurement:

Get More Info

Related Articles:

3d rendering of industrial workspace showing storytellingon computer screen. All screen graphics are made up.

Improving Efficiency in Pharma Manufacturing Through IoT Technologies

The unprecedented power of the Internet of Things (IoT) has urged a vast majority of the companies in the manufacturing sector to make use of this technology to unlock limitless potential. Pharmaceutical manufacturing companies are no exception to this, as IoT has the potential to revolutionize all aspects of the pharmaceutical manufacturing process from drug discovery to manufacturing. IoT in pharma manufacturing coupled with big data and advanced analytics can scrutinize massive amounts of data that can be harnessed to improve manufacturing efficiency.SE_Demo2

IoT in Pharma Manufacturing

Connected Equipment

Pharma manufacturing companies rely heavily on batch manufacturing and equipment is usually self-contained. So it requires men and materials to move constantly on the shop floor. Although industrial automation and control technologies are widely used, real-time status of equipment is not readily accessible to make informed decisions that can improve equipment effectiveness. IoT technology can assist to maintain the safety and efficacy of drug products by maintaining specific storage condition and providing extended visibility into shop-floor activities.

Real-Time Visibility into Warehouse Operations

Warehousing is a critical component for every pharmaceutical manufacturing companies. Shortage of certain medicines can have serious consequences, on the other hand overstocking can lead to product wastages and higher inventory holding costs. Since pharma companies maintain numerous warehouses spread across vast geographies, warehousing operations amount for a vast majority of the pharma logistics cost. Smart warehouses can increase real-time visibility into the operations by tracking products in the warehouse and optimally utilize operators and transport equipment. IoT technology is essential in pharma supply chain as it can report inconsistencies, optimize warehouse floor space, and monitor storage of sensitive medicines.

Controlling Cold Chain Conditions

Pharmaceutical manufacturers need to be very careful while handling biologics, which are highly sensitive to storage conditions. Such biologics are high-value items with shorter shelf lives carrying strict temperature requirements. IoT technology makes it possible to remotely monitor the condition of the drug and ensure that ambient temperature is maintained at temperature-controlled containers.

Remote Fleet Management

Use of digital technology such as GPS systems can allow remote monitoring of the transport process and ensure shipment visibility throughout the supply chain. A multitude of data regarding vehicle location, vehicle performance, and view of the driver can be collected which can be processed and decisions to optimize fleet management can be taken remotely. Consequently, it can drastically reduce the time-to-market, prevent product spoilage, and lower carrying costs.

For more information on IoT in pharma manufacturing, pharma supply chain, cold chain logistics, and pharmaceutical manufacturing companies:

Get More Info

Related Articles:

IR21

The Imperative Need of Procurement Process in the Pharma Industry

Today, we can see an increasing trend amongst top companies opting for better procurement management to save costs and remain competitive in the marketplace. Procurement is more than just a cost-cutting tool. By reducing waste and optimizing resources, pharma companies can significantly boost their efficiency. The pharma industry has to tackle a lot of modern-day challenges right from generic drugs, personalized medicines, rising research and development cost to expensive clinical trials. Improvement of the procurement process in pharma industry can solve such problems and improve the industry profitability.SE_Demo2

Why should the pharma industry opt for better procurement practices?

Driving Innovation

Innovation in Pharma industry does not concern only towards drug innovation. Innovation in procurement and sourcing processes could lead pharma companies to achieve monumental savings opportunities. For instance, successful pharma companies can create innovative incentive models for suppliers to suggest new ideas on ways to reach new market via new sales channel. By ensuring spend control and collaboration across divisions and functions with their supplier network as well as internal stakeholder’s, companies can create more opportunities for innovation.

Collaboration Across Business Functions

When it comes to conducting a clinical trial, business managers are looking to outsource the process to a capable strategic partner. However, they are quite reluctant to place such decisions in the hand of the procurement team. It has been evident that when procurement function takes over the execution of such activities, they strive to find the best partner and negotiate better terms that will drive the overall performance as well as the output. Additionally, clear procurement roles and responsibilities are a must to ensure smooth flow of operations.

Managing Indirect Spend

A vast majority of spend in a typical pharma company goes to indirect spend categories such as IT, MRO, office supplies, travel, logistics, and marketing. Such spends account for millions of dollars that could be saved because of a better procurement process. By improving the procurement process in the pharma industry with strict policies, proper tools, and providing full spend visibility, companies can improve savings from indirect spends and force regulatory compliance.

For more information on procurement in the pharma industry, pharma procurement, procurement process in the pharma industry, and indirect spends:

Get More Info

Related Articles:

IR6

Category Market Intelligence Helps an Oncology Drugs Manufacturer Better Understand their Customers

Category Overview

Today, leading organizations in the pharmaceutical space are under relentless pressure to curtail costs while delivering effective care to patients in terms of treatment modalities. Leading organizations in the oncology drugs manufacturing space are facing the need for category market intelligence to offer reliable products without compromising on the quality. Category market intelligence helps businesses understand the market effectiveness in terms of the competitors and their supply chain activities and the supplier diversity. In the medical drugs space, manufacturers can further assess the current performance of the market and gain actionable insights into the latest trends and developments in the drugs space.

As the number of cancer patients is staggering, the necessity for oncology drugs is at its peak with a considerable number of manufacturers offering immediate medical assistance. To reach out to the niche customer segments, the client advocated the need for SpendEdge’s category market intelligence solutions. With years of expertise in offering a plethora of services, SpendEdge’s category market intelligence analysts assisted the client to gain insights on the buying preferences of the customers and helped the client understand the potential risks associated with procurement.

The Procurement Pain Point and Insights Offered

A renowned oncology drugs manufacturer was facing predicaments understanding their customers and preferences. request free proposalThe client wanted to understand the market landscape in terms of market dynamics, drivers, and niches. Furthermore, the client wanted to devise a robust SWOT analysis to identify the barriers, opportunities, and market trends in the healthcare industry. The client further wanted to leverage the use of category management to improve cost savings without compromising the quality of the products. With the help of category management solutions, the client wanted to capitalize on the opportunities to derive maximum value and gain better visibility into the supply chain activities.

To better understand the customers and devise an effective marketing strategy, SpendEdge’s category management experts carried out a blended approach comprising of interviews and discussions with leading stakeholders in the healthcare industry. Furthermore, the experts collated information from various proprietary sources such as paid industry databases, healthcare organizations, hospitals, newsletters, and magazines.

SpendEdge’s robust category market intelligence helped the oncology drugs manufacturer understand the suppliers and the cost structure. Moreover, the solution helped the oncology drugs client effectively understand the competitor’s category strategies and assess the potential risks, compliance, and environmental policy and maintain effective supplier relationship.

Key questions answered in this category market intelligence include

Category market intelligence- oncology

Business Outcome

With the help of this category market intelligence solution, the oncology drugs manufacturer was able to effectively keep track of the commodities and materials in the healthcare industry. Also, the solution helped the client carry out an effective analysis to gain better insights into the buyers, the potential risks, and product portfolios.

Want to know more about our category market intelligence solution?

request free proposal

Global-Meetings-and-Events-Market_CMST31

Regulatory Framework Guiding the Pharmaceutical Packaging Industry

Pharmaceutical packaging is a matter of serious concern for both the drug manufacturers and consumers. The primary objective of pharmaceutical packaging is to protect the medicine from external factors such as heat, moisture, oxygen, and contamination to Request Free Sampleensure drug efficacy, patient safety, and extended shelf life. Since pharmaceuticals are sensitive to fluctuations in environmental conditions and contaminations, suppliers must comply with government rules and regulations regarding the packaging of medicines. Here are some of the regulatory frameworks that pharmaceutical packaging suppliers must comply by:

Anti-Tampering Regulations

Drug tampering cases like Tylenol tampering with potassium cyanide in the past have resulted in deaths. After the Tylenol case, the FDA issued the Federal Anti-Tampering Act, requiring OTC drug manufacturers to create tamper resistant packaging. FDA rules for OTC drugs are relatively simple as well. For instance, two-piece hard gelatin capsules need a minimum of two tamper resistant packaging features, whereas one feature is sufficient for everything else. Shrink wrap, blister wrap, bubble packs, HIS liners, sealed metal tubes, and aerosol containers are some of the options available for manufacturers to develop tamper resistant packaging.

Labelling Regulations

The pharmaceutical packaging industry is highly regulated in terms of labeling requirements. Key players in the pharmaceutical packaging industry must adhere to the Fair Packaging and Labeling Act (1967) in the US, which mandates the label to include product identity, manufacturer and supplier address, contents, net quantity, and prescription information.

Pharmacopoeia Standards

Pharmaceutical packaging suppliers must comply with the global pharmacopeia standards set by WHO to ensure product quality. For instance, water used in packaging processes should be EP grade as it ensures high purity of water and meets worldwide specifications. Although WHO standards are globally accepted, countries can modify the standards to suit their own needs; thus, forming standards such as European Pharmacopoeia – 5.12 and British Pharmacopoeia chemical reference substances (BPCRS).

Read more about the rules and regulations in the pharmaceutical packaging market along with supply market landscape, pricing, and procurement insights in SpendEdge’s upcoming procurement report on the pharmaceutical packaging market.

CTA view full reportRelated Articles:

Global-Meetings-and-Events-Market_CMST31

Procurement Market Intelligence Study on the Consulting Sector

The Procurement Pain Point

 

With a keen eye on identifying the best procurement practices and future market opportunities, the client – a leading a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs – approached SpendEdge to engage in a procurement market intelligence study that would help them gain effective insights into the consulting sector. The procurement intelligence engagement also helped the client gain comprehensive insights into the supply market, strategic sourcing, pricing, and procurement strategies specific to the consulting category.

The primary objective of this procurement market intelligence engagement was to help the client gain a detailed understanding of the market dynamics, outsourcing trends, price levels in the market, best practices around category management strategies, and develop recommendations based on category strategy implementation.

To meet the specific category requirements of market-leading companies in the consulting sector, SpendEdge’s experienced procurement market intelligence team tracked latest developments and procurement trends in theCapture market through secondary journals and reached out to key stakeholders, thought leaders, end users of consulting services, procurement experts to understand their views on the market. Our procurement market intelligence specialists also spoke to key stakeholders to understand how the consulting services market would grow in the short and long term to validate the market size and procurement market intelligence model developed for this industry.

Procurement Insights Offered and the Outcome

 

To address the various procurement market intelligence requirements specific to the client’s needs, we deployed a dedicated team of sourcing and procurement analysts working under a project manager with significant experience in conducting and managing similar procurement market intelligence studies specific to the consulting category. The insights offered followed a blended approach of primary and secondary research followed by data analysis and category specific insights development.

CaptureIn just four weeks, the client – a leading pharmaceutical company – was able to gain a better understanding of the different types of consulting services, including legal, quality, finance, strategic consulting. The procurement market intelligence service offered by our team also helped the global client understand the global market landscape by analyzing the market segments, trends, drivers, and challenges. Additionally, an assessment of the current outsourcing trends, pricing models, procurement best practices, and strategies was also offered to help the client identify current and future market opportunities.

Some of the additional questions answered by our procurement market intelligence study includes

  1. What are the best practices followed by industry peers specific to consulting services procurement?
  2. What are the typical short, middle, and long term goals and what are their key benefits?
  3. What are the key priorities considered for optimization of consulting services procurement?
  4. How to prioritize action plans?
  5. What are the key contracting and engagement best practices followed by peer group companies?
  6. What are the key strategies implemented for cost savings and supplier consolidation?

 

This case study offers information on how our procurement market intelligence study helped a global pharmaceutical client understand the market space for the consulting sector better.

 

Want to know more?

 

Capture

 

Consulting Sector

Request free proposal